Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Invokana
Invokana
4 Things Johnson & Johnson Should Address When it Reports Its Q3 Results
Motley Fool
Sat, 10/10/15 - 09:09 am
JNJ
earnings
Invokana
daratumumab
devices
Did Eli Lilly Just Get a Leg Up on Johnson & Johnson?
Motley Fool
Tue, 09/29/15 - 10:28 pm
Eli Lilly
JNJ
Jardiance
Invokana
diabetes
Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana
Fierce Pharma Marketing
Mon, 09/14/15 - 11:01 am
diabetes
FDA
Invokana
JNJ
Jardiance
Boehringer Ingelheim
Eli Lilly
Bydureon, Invokana, Xarelto brand teams shelled out most to doctors in 2014
Fierce Pharma Marketing
Wed, 07/8/15 - 11:34 am
Bydureon
Invokana
Xarelto
physicians
physician payments
FDA warns on newer class of type 2 diabetes drugs
Yahoo/Reuters
Sat, 05/16/15 - 02:04 pm
FDA
diabetes
type 2 diabetes
AstraZeneca
Farxiga
Eli Lilly
Jardiance
Boehringer Ingelheim
JNJ
Invokana
SGLT2 inhibitor
J&J's Invokana fends off new SGLT2 rivals to hit $278M in Q1
Fierce Pharma Marketing
Wed, 04/15/15 - 09:28 am
JNJ
Invokana
SGLT2 inhibitor
diabetes
Boehringer Ingelheim
Eli Lilly
Jardiance
Glyxambi
Will Diabetes Drugs Enter The Anti-Obesity Space?
Seeking Alpha
Mon, 12/8/14 - 08:30 am
diabetes
obesity
Arena Pharmaceuticals
Novo Nordisk
AstraZeneca
Orexigen
Vivus
Farxiga
Victoza
Invokana
Janssen Is Working Its Way Toward Anti-Obesity
Seeking Alpha
Tue, 11/18/14 - 09:59 am
Janssen
obesity
Invokana
Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land
Fierce Pharma Marketing
Thu, 06/26/14 - 10:21 am
drug launches
Tecfidera
Sovaldi
Aubagio
Imbruvica
Tivicay
Breo Ellipta and Anoro Ellipta
Kadcyla
Invokana
Pomolyst
Johnson & Johnson's New Diabetes Drug: A Blockbuster in the Making?
Motley Fool
Mon, 04/21/14 - 10:17 am
JNJ
diabetes
Invokana
J&J's combo diabetes drug held up by FDA
PM Live
Mon, 12/16/13 - 08:29 am
canagliflozin
diabetes
JNJ
metformin
FDA
Invokana
Johnson & Johnson Continues To Ride The Success Of Its Immunology And Oncology Drugs
Seeking Alpha
Fri, 10/18/13 - 10:07 am
JNJ
Remicade
Simponi
Stelara
Invokana
CHMP thumbs up for 11 new drugs
Pharma Times, UK
Mon, 09/23/13 - 09:33 am
Europe
drug approvals
Kadcyla
Roche
Bayer
Xofigo
Abilify Maintena
Otsuka
Lundbeck
Memantine Accord
Accord Healthcare
Levodopa Carbidopa Entacapone Sandoz
Orion
Vitekta
Gilead
Janssen-Cilag
Invokana
Novo Nordisk
NovoEight
AstraZeneca
Fluenz Tetra
GSK
Relvar Ellipta
Lidocaine/Prilocaine Plethora
Plethora Solutions
Johnson & Johnson's 3 Most Promising Drugs (video)
Motley Fool
Sat, 08/24/13 - 12:01 pm
Zytiga
Pharmacyclics
JNJ
Invokana
ibrutinib
The Diabetes Pipeline With a Clog
Motley Fool
Mon, 07/22/13 - 06:02 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
JNJ
SGLT2 inhibitor
Forxiga
Invokana
empagliflozin
3 Things You Need to Watch at Johnson & Johnson
Motley Fool
Wed, 04/17/13 - 04:38 pm
JNJ
devices
Invokana
Stelara
Johnson & Johnson's New Diabetes Drug And Its Competitors
Seeking Alpha
Tue, 04/2/13 - 09:52 am
JNJ
diabetes
Invokana
Merck
Januvia
Byetta
Bristol-Myers Squibb
Diabetes Drug Could Rake Hundreds of Millions for J&J
Wall St. Cheat Sheet
Mon, 04/1/13 - 10:31 am
JNJ
Invokana
diabetes
FDA OKs first-of-a-kind diabetes drug from J&J
Yahoo/AP
Sat, 03/30/13 - 11:01 am
JNJ
diabetes
Invokana
type 2 diabetes
Johnson & Johnson Waits for FDA Ruling on new Diabetes Drug
Motley Fool
Fri, 03/29/13 - 10:49 am
FDA
JNJ
diabetes
Invokana
Pages
« first
‹ previous
1
2
3
4
next ›
last »